Effect of Empagliflozin on Left Ventricular Mass in Patients with Type 2 Diabetes and Coronary Artery Disease: The EMPA-HEART CardioLink-6 Randomized Clinical Trial

Topics: 

Citation
Verma S, et al. Circulation 2019.140:1693-1702.